Use of standard anticoagulation therapy in Behcet diseases is controversial,
the best management of vascular thrombosis in Behcet disease is IV Methylprednisolone/ cyclophosphamide, AZA, Aspirin.
However Anticoagulants (warfarin) may be considered for reducing the risk of post-thrombotic syndrome, but the risk of bleeding should be evaluated carefully because of an increased prevalence of accompanying arterial aneurysms in such patients.